MRKR
Marker Therapeutics Inc
NASDAQ: MRKR · HEALTHCARE · BIOTECHNOLOGY
$1.46
+0.69% today
Updated 2026-04-30
Market cap
$24.18M
P/E ratio
—
P/S ratio
6.82x
EPS (TTM)
$-0.79
Dividend yield
—
52W range
$1 – $2
Volume
0.1M
Marker Therapeutics Inc (MRKR) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-170.70%
ROE
-68.80%
ROA
-37.80%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | — | $-1.30M | — | — | — |
| 2007 | — | $-3.89M | — | — | — |
| 2008 | — | $-2.20M | — | — | — |
| 2009 | — | $-4.46M | — | — | — |
| 2010 | — | $-5.09M | — | — | — |
| 2011 | — | $-2.03M | — | — | — |
| 2012 | — | $-5.86M | — | — | — |
| 2013 | — | $-5.53M | — | — | — |
| 2014 | $0.00 | $-30.88M | — | — | — |
| 2015 | $0.00 | $-34.07M | — | — | — |
| 2016 | $0.00 | $-2.46M | — | — | — |
| 2017 | $183064.00 | $-10.98M | -2,768.43% | -6,271.03% | -5,998.99% |
| 2018 | $205994.00 | $-147.96M | -60,094.95% | -71,930.25% | -71,826.36% |
| 2019 | $213194.00 | $-21.43M | -5,887.41% | -10,567.28% | -10,050.92% |
| 2020 | $466785.00 | $-28.71M | -3,944.86% | -6,188.29% | -6,149.73% |
| 2021 | $1.24M | $-41.88M | -154.70% | -3,179.32% | -3,372.68% |
| 2022 | $3.51M | $-29.93M | -240.64% | -563.28% | -851.87% |
| 2023 | $3.31M | $-8.24M | -214.60% | -440.37% | -248.76% |
| 2024 | $6.59M | $-10.73M | -104.33% | -168.69% | -162.82% |
| 2025 | $3.55M | $-12.16M | — | -350.68% | -342.96% |